Shao-Lee Lin has an estimated net worth of $18 Million. This is based on reported shares across multiple companies, which include Horizon Therapeutics Public Ltd Co, Surrozen, Inc./DE, Principia Biopharma Inc., Third Harmonic Bio, Inc., ACELYRIN, Inc., and Cue Biopharma, Inc..

2023 was Shao-Lee Lin's most active year for acquiring shares with 12 total transactions. Shao-Lee Lin's most active month to acquire stocks was the month of April. 2023 was Shao-Lee Lin's most active year for disposing of shares, totalling 11 transactions. Shao-Lee Lin's most active month to dispose stocks was the month of December. 2023 saw Shao-Lee Lin paying a total of $0.00 for 6,555,891 shares, this is the most they've acquired in one year. In 2023 Shao-Lee Lin cashed out on 6,285,393 shares for a total of $8,324,949.51, their largest year based on trade value.